Treatment options for recurrent high-grade gliomas

od Birk, Harjus S, Han, Seunggu J, Butowski, Nicholas A
Izdano u CNS Oncol (2017)

Early tumor growth between initial resection and radiotherapy of glioblastoma: incidence and impact on clinical outcomes

od Villanueva-Meyer, Javier E., Han, Seunggu J., Cha, Soonmee, Butowski, Nicholas A.
Izdano u J Neurooncol (2017)

Interventional MRI-guided catheter placement and real time drug delivery to the central nervous system

od Han, Seunggu J., Bankiewicz, Krystof, Butowski, Nicholas A., Larson, Paul S., Aghi, Manish K.
Izdano u Expert Rev Neurother (2016)

The Development of Reduced Diffusion Following Bevacizumab Therapy Identifies Regions of Recurrent Disease in Patients with High-grade Glioma

od Barajas, Ramon F., Butowski, Nicholas A., Phillips, Joanna J., Aghi, Manish K., Berger, Mitchel S., Chang, Susan M., Cha, Soonmee
Izdano u Acad Radiol (2016)

MRI Features and IDH Mutational Status in Grade II Diffuse Gliomas: Impact on Diagnosis and Prognosis

od Villanueva-Meyer, Javier E., Wood, Matthew D., Choi, Byungse, Mabray, Marc C., Butowski, Nicholas A., Tihan, Tarik, Cha, Soonmee
Izdano u AJR Am J Roentgenol (2017)

Assessment of perfusion MRI-derived parameters in evaluating and predicting response to antiangiogenic therapy in patients with newly diagnosed glioblastoma

od Essock-Burns, Emma, Lupo, Janine M., Cha, Soonmee, Polley, Mei-Yin, Butowski, Nicholas A., Chang, Susan M., Nelson, Sarah J.
Izdano 2011

Evaluation of diffusion parameters as early biomarkers of disease progression in glioblastoma multiforme(†)

od Khayal, Inas S., Polley, Mei-Yin C., Jalbert, Llewellyn, Elkhaled, Adam, Chang, Susan M., Cha, Soonmee, Butowski, Nicholas A., Nelson, Sarah J.
Izdano 2010

Disseminated progression of glioblastoma after treatment with bevacizumab

od Bloch, Orin, Safaee, Michael, Sun, Matthew Z., Butowski, Nicholas A., McDermott, Michael W., Berger, Mitchel S., Aghi, Manish K., Parsa, Andrew T.
Izdano u Clin Neurol Neurosurg (2013)

Phase I Study of RO4929097 with Bevacizumab in Patients with Recurrent Malignant Glioma

od Pan, Edward, Supko, Jeffrey G., Kaley, Thomas J., Butowski, Nicholas A., Cloughesy, Timothy, Jung, Jinkyu, Desideri, Serena, Grossman, Stuart, Ye, Xiaobu, Park, Deric M.
Izdano u J Neurooncol (2016)

Phase II trial of 7 days on/7 days off temozolmide for recurrent high-grade glioma

od Han, Seunggu J., Rolston, John D., Molinaro, Annette M., Clarke, Jennifer L., Prados, Michael D., Chang, Susan M., Berger, Mitchel S., DeSilva, Ashley, Butowski, Nicholas A.
Izdano 2014

The Effect of Timing of Concurrent Chemoradiation in Patients With Newly Diagnosed Glioblastoma

od Han, Seunggu J., Rutledge, William C., Molinaro, Annette M., Chang, Susan M., Clarke, Jennifer L., Prados, Michael D., Taylor, Jennie W., Berger, Mitchel S., Butowski, Nicholas A.
Izdano u Neurosurgery (2015)

Impact of Timing of Concurrent Chemoradiation for Newly Diagnosed Glioblastoma: A Critical Review of Current Evidence

od Han, Seunggu J., Englot, Dario J., Birk, Harjus, Molinaro, Annette M., Chang, Susan M., Clarke, Jennifer L., Prados, Michael D., Taylor, Jennie W., Berger, Mitchel S., Butowski, Nicholas A.
Izdano u Neurosurgery (2015)

A single-institution phase II trial of radiation, temozolomide, erlotinib, and bevacizumab for initial treatment of glioblastoma

od Clarke, Jennifer L., Molinaro, Annette M., Phillips, Joanna J., Butowski, Nicholas A., Chang, Susan M., Perry, Arie, Costello, Joseph F., DeSilva, Ashley A., Rabbitt, Jane E., Prados, Michael D.
Izdano 2014

Phase-2 Trial of palbociclib in adult patients with recurrent RB1-positive Glioblastoma

od Taylor, Jennie W., Parikh, Mili, Phillips, Joanna J., James, C. David, Molinaro, Annette M., Butowski, Nicholas A., Clarke, Jennifer L., Oberheim-Bush, Nancy Ann, Chang, Susan M., Berger, Mitchel S., Prados, Michael
Izdano u J Neurooncol (2018)

Attitudes toward fertility and fertility preservation in women with glioma

od Stiner, Rachel K, Clarke, Jennifer L, Sinha, Nikita, Chan, Jessica, Letourneau, Joseph M, Niemasik, Erin E, Rabbitt, Jane E, Chang, Susan M, Butowski, Nicholas A, Prados, Michael D, Rosen, Mitchell P
Izdano u Neurooncol Pract (2019)

Phase II trial of pazopanib (GW786034), an oral multi-targeted angiogenesis inhibitor, for adults with recurrent glioblastoma (North American Brain Tumor Consortium Study 06-02)

od Iwamoto, Fabio M., Lamborn, Kathleen R., Robins, H. Ian, Mehta, Minesh P., Chang, Susan M., Butowski, Nicholas A., DeAngelis, Lisa M., Abrey, Lauren E., Zhang, Wei-Ting, Prados, Michael D., Fine, Howard A.
Izdano 2010

A single institution retrospective analysis on survival based on treatment paradigms for patients with anaplastic oligodendroglioma

od Bush, Nancy Ann Oberheim, Young, Jacob S., Zhang, Yalan, Dalle Ore, Cecilia L., Molinaro, Annette M., Taylor, Jennie, Clarke, Jennifer, Prados, Michael, Braunstein, Steve E., Raleigh, David R., Chang, Susan M., Berger, Mitchel S., Butowski, Nicholas A.
Izdano u J Neurooncol (2021)

A randomized controlled phase III study of VB-111 combined with bevacizumab vs bevacizumab monotherapy in patients with recurrent glioblastoma (GLOBE)

od Cloughesy, Timothy F, Brenner, Andrew, de Groot, John F, Butowski, Nicholas A, Zach, Leor, Campian, Jian L, Ellingson, Benjamin M, Freedman, Laurence S, Cohen, Yael C, Lowenton-Spier, Noa, Rachmilewitz Minei, Tamar, Fain Shmueli, Shifra, Wen, Patrick Y
Izdano u Neuro Oncol (2020)

Heat-shock protein peptide complex–96 vaccination for recurrent glioblastoma: a phase II, single-arm trial

od Bloch, Orin, Crane, Courtney A., Fuks, Yelena, Kaur, Rajwant, Aghi, Manish K., Berger, Mitchel S., Butowski, Nicholas A., Chang, Susan M., Clarke, Jennifer L., McDermott, Michael W., Prados, Michael D., Sloan, Andrew E., Bruce, Jeffrey N., Parsa, Andrew T.
Izdano 2014

Expression and prognostic impact of immune modulatory molecule PD-L1 in meningioma

od Han, Seunggu J., Reis, Gerald, Kohanbash, Gary, Shrivastav, Shruti, Magill, Stephen T., Molinaro, Annette M., McDermott, Michael W., Theodosopoulos, Philip V., Aghi, Manish K., Berger, Mitchel S., Butowski, Nicholas A., Barani, Igor, Phillips, Joanna J., Perry, Arie, Okada, Hideho
Izdano u J Neurooncol (2016)